Methods used for liver evaluation: a) Transient Elastography (TE) and... | Download Scientific Diagram
Risk-stratified screening for chronic liver disease using vibration-controlled transient elastography (Fibroscan) | Gastrointestinal Nursing
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
Non-Invasive Assessment of Liver Fibrosis by Vibration-Controlled Transient Elastography (Fibroscan®) | IntechOpen
Frontiers | Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study
Measurement of Liver Stiffness and Liver Fat Using Vibration-Controlled Transient Elastography Has Excellent Reproducibility and Intra-Operator Reliability in an Unselected Community-Based Cohort | Internal Medicine Residency Program
New diagnostic technique to evaluate hepatic steatosis using the attenuation coefficient on ultrasound B mode | PLOS ONE
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography - Myers - 2012 - Liver International - Wiley Online Library
The FibroScan® Advantage in Early NASH Clinical Studies
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
PDF) Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C | veronique miette - Academia.edu
Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease - Vuppalanchi - 2018 - Hepatology - Wiley Online Library
Cureus | Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan® - ScienceDirect
![PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1443873eaff02b60860bb714f18a57a40088a5c/2-Figure1-1.png "PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar")
PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar
Ultrasonography
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease - Clinical Gastroenterology and Hepatology
Untitled Document
Distribution of controlled attenuation parameter (CAP) values in... | Download Scientific Diagram
Application of transient elastography in nonalcoholic fatty liver disease
PREVALENCE AND RISK FACTORS OF HEPATIC STEATOSIS AND FIBROSIS IN AMERICAN ADULTS: A POPULATION-BASED STUDY
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | SpringerLink
Diagnostic of hepatic fibrosis with the XL probe of the Fibroscan versus biopsies in patients candidates to bariatric surgery - Clinical Nutrition ESPEN
Schematic diagram of vibration-controlled transient lastography setup... | Download Scientific Diagram
Individual patient data meta-analysis of controlled attenuation parameter ( CAP) technology for assessing steatosis - ScienceDirect
FibroScan® 402 – KNS Canada Inc.
